Nihon Kohden (NHNKY) Stock Price, News & Analysis

Company Overview

Nihon Kohden Corporation is a Tokyo-based medical electronics company founded in 1951. Specializing in the design, development and manufacture of a wide range of healthcare devices, the company has built a reputation for innovation in patient monitoring, neurological diagnostics and life support equipment. Over its history, Nihon Kohden has introduced numerous industry‐first technologies, including advanced electrocardiography systems and portable defibrillators, to support clinicians in critical care environments.

The company’s primary product portfolio encompasses patient monitors, defibrillators, electroencephalographs (EEG) and electrocardiographs (ECG), as well as in vitro diagnostic instruments such as hematology analyzers and immunoassay systems. Nihon Kohden’s patient monitoring solutions offer real‐time vital signs tracking, while its neurodiagnostic devices provide high‐resolution brainwave analysis for epilepsy and sleep disorder assessments. In vitro diagnostics products deliver automated testing capabilities for clinical laboratories, facilitating rapid and reliable blood cell counts and biomarker detection.

Operating in more than 140 countries, Nihon Kohden maintains a global network of sales, service and distribution centers across North America, Europe, Asia and the Middle East. The company’s international subsidiaries and partnerships enable localized technical support and training for healthcare professionals, ensuring optimal use of its equipment in diverse clinical settings. Manufacturing facilities in Japan and overseas adhere to stringent quality standards, reflecting the company’s commitment to safety and performance.

Guided by a board of directors and executive leadership focused on long‐term growth, Nihon Kohden invests heavily in research and development. The company holds numerous patents in biomedical technology and collaborates with universities, hospitals and research institutes to advance new diagnostic and monitoring solutions. Through ongoing innovation and global outreach, Nihon Kohden aims to enhance patient care and contribute to improvements in healthcare delivery worldwide.

Key Stats

• Today's Range: $10.73 to $12.85
• 50-Day Range: $10.81 to $13.72
• 52-Week Range: $9.86 to $17.28
• Volume: 3,326 shs
• Average Volume: 5,642 shs
• Market Capitalization: $2.10 billion
• P/E Ratio: 21.92
• Dividend Yield: 2.12%
• Price Target: N/A
• Consensus Rating: N/A

Nihon Kohden Stock Analysis - MarketRank™

Nihon Kohden scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Nihon Kohden.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nihon Kohden is 21.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.26.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nihon Kohden is 21.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.58.

Price to Book Value per Share Ratio

Nihon Kohden has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Nihon Kohden has been sold short.

Short Interest Ratio / Days to Cover

Nihon Kohden has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nihon Kohden has recently decreased by 50.00%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Nihon Kohden pays a meaningful dividend of 2.32%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Nihon Kohden does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Nihon Kohden is 46.43%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the float of Nihon Kohden has been sold short.

Short Interest Ratio / Days to Cover

Nihon Kohden has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nihon Kohden has recently decreased by 50.00%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.82

News Sentiment

Nihon Kohden has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Nihon Kohden this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nihon Kohden insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.10% of the stock of Nihon Kohden is held by institutions.

NHNKY Stock Analysis - Frequently Asked Questions

How have NHNKY shares performed this year?

Nihon Kohden's stock was trading at $14.35 on January 1st, 2025. Since then, NHNKY shares have decreased by 14.4% and is now trading at $12.2775.

How were Nihon Kohden's earnings last quarter?

Nihon Kohden Corporation (OTCMKTS:NHNKY) announced its quarterly earnings results on Tuesday, May, 13th. The company reported $0.18 earnings per share (EPS) for the quarter. The firm earned $439.11 million during the quarter. Nihon Kohden had a net margin of 6.23% and a trailing twelve-month return on equity of 7.20%.

How do I buy shares of Nihon Kohden?

Shares of NHNKY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 7/31/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:NHNKY
• CIK: 1543726
• Web: www.nihonkohden.com
• Phone: (135) 996-8000
• Fax: 813-5996-8100
• Employees: 6,114
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.56
• Trailing P/E Ratio: 21.92
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $93.05 million
• Net Margins: 6.23%
• Pretax Margin: 9.57%
• Return on Equity: 7.20%
• Return on Assets: 5.43%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.53
• Quick Ratio: 1.76

Sales & Book Value

• Annual Sales: $1.48 billion
• Price / Sales: 1.42
• Cash Flow: $0.71 per share
• Price / Cash Flow: 17.28
• Book Value: $7.00 per share
• Price / Book: 1.75

Miscellaneous

• Outstanding Shares: 170,960,000
• Free Float: N/A
• Market Cap: $2.10 billion
• Optionable: Not Optionable
• Beta: 0.35